| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Chief Innovation Officer | Ordinary Shares | 171K | $2.79M | $16.30 | Feb 27, 2024 | Direct |
| NovoCure Ltd | Chief Innovation Officer | Stock Options (Right to buy) | 125K | $2.04M | $16.30 | Feb 27, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Feb 27, 2024 | 2 | $3.37M | 4 | Feb 29, 2024 | Chief Innovation Officer |
| NVCR | NovoCure Ltd | Jun 30, 2023 | 1 | $10.8K | 4 | Jul 6, 2023 | Chief Innovation Officer |
| NVCR | NovoCure Ltd | Mar 3, 2023 | 2 | $0 | 4 | Mar 6, 2023 | Chief Innovation Officer |
| NVCR | NovoCure Ltd | Feb 28, 2023 | 2 | $1.66M | 4 | Mar 2, 2023 | Chief Innovation Officer |
| NVCR | NovoCure Ltd | Jan 5, 2023 | 6 | -$854K | 4 | Jan 9, 2023 | Chief Science Officer |
| NVCR | NovoCure Ltd | Jul 5, 2022 | 1 | $16.6K | 4 | Jul 7, 2022 | Chief Science Officer |
| NVCR | NovoCure Ltd | Mar 3, 2022 | 3 | $2.85M | 4 | Mar 7, 2022 | Chief Science Officer |
| NVCR | NovoCure Ltd | Jan 6, 2022 | 1 | $2.23K | 4 | Jan 12, 2022 | Chief Science Officer |
| NVCR | NovoCure Ltd | Jul 6, 2021 | 1 | $15.5K | 4 | Jul 8, 2021 | Chief Science Officer |
| NVCR | NovoCure Ltd | May 10, 2021 | 4 | -$889K | 4 | May 12, 2021 | Chief Science Officer |